Briefs

BETHESDA, Md.--(BUSINESS WIRE)--Sept. 7, 2001
InforMax, Inc. (Nasdaq:INMX), a leading global provider of
bioinformatics solutions that enable High-Throughput Research(TM),
today announced the release of Version 7.0 of Vector NTI(R) Suite, an
integrated sequence analysis and data management desktop software
package for molecular biology and genomics research.

Vector NTI Suite v.7.0 offers increased functionality across all of
the suite application programs - Vector NTI, AlignX(R), BioPlot(R),
and ContigExpress(R). Notable enhancements include optimised
recombinant strategies and protocols, enhanced primer design and
analysis capabilities, and an enhanced BLAST viewer for customized
visualization of sequence data.

Additionally, Vector NTI Suite 7.0 features improved utilities for
sequence alignment and contig assembly.

"A comprehensive and integrated software toolset is essential to
enable sophisticated problem solving and the increased productivity
required in today's research environment. Our experience with
customers has shown that tightly integrating in silico data mining and
analysis processes with lab productivity tools to validate the in
silico results yields significant improvements in both the efficiency
and effectiveness of the overall target discovery and validation
process." said Alex Titomirov, InforMax Chief Executive Officer. "The
continued development of our Vector NTI Suite affirms InforMax's
commitment to advancing the science of bioinformatics through the
delivery of unique software and services that create a High-Throughput
Research environment."

Through the delivery of software and services that support
High-Throughput Research (HTR), InforMax provides researchers with a
means of minimizing the time and cost of discovering and validating
valuable targets for pharmaceutical, therapeutic, and diagnostic
development.

Vector NTI Suite, the industry's most comprehensive desktop software
solution available for enhancing laboratory productivity, includes
application programs for data management, experimental simulation,
strategic recombinant design, mapping and illustration, protein and
nucleic acid sequence analysis, multiple sequence alignment, and
fragment assembly.

For more information, see http://www.informaxinc.com.